Figure 3
Figure 3. Impact of MDM2 and p53 expression on PFS in de novo DLBCL patients with WT- or MUT-p53.

Impact of MDM2 and p53 expression on PFS in de novo DLBCL patients with WT- or MUT-p53.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal